clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Upper Extremity Deep Vein Thrombosis D056824 1 associated lipids
Pseudomyxoma Peritonei D011553 1 associated lipids
Eye Infections D015817 1 associated lipids
Gastritis, Hypertrophic D005758 1 associated lipids
Buruli Ulcer D054312 1 associated lipids
Tuberculosis, Spinal D014399 1 associated lipids
Hypoproteinemia D007019 1 associated lipids
Myxoma D009232 1 associated lipids
Epilepsy, Partial, Motor D020938 1 associated lipids
Cutaneous Fistula D017577 1 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Saint-Marc T et al. [Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases]. 1993 Presse Med pmid:8121903
Fonquernie L et al. [Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment]. 2000 Presse Med pmid:10705894
Mégraud F [Helicobacter pylori infection: Review and practice]. Presse Med pmid:20627443
Blondon H [Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?]. 1999 Presse Med pmid:10629694
Esvant H et al. [Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. 1993 Presse Med pmid:8337221
Mariani-Kurkdjian P et al. [Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France]. 2004 Presse Med pmid:15257225
Bigard MA [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies]. 2001 Presse Med pmid:11603094
Khalil T et al. [Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes]. 2007 Presse Med pmid:17360147
Hajjaji N et al. [Mycobacterium chelonae myositis]. 2004 Presse Med pmid:15614176
Bismuth + metronidazole + tetracycline. Why risk adding bismuth? 2013 Prescrire Int pmid:23662315
Clarithromycin in coronary heart disease: excess mortality in the long term. 2006 Prescrire Int pmid:17167932
Severe colchicine-macrolide interactions. 2003 Prescrire Int pmid:12602385
Arnold Ch et al. [88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?]. 2010 Praxis (Bern 1994) pmid:21125536
Plate A [Not Available]. 2016 Praxis (Bern 1994) pmid:27606919
Naumann UK et al. [Brochiectasis (in the adult)]. 2007 Praxis (Bern 1994) pmid:17616034
Treiber G and Malfertheiner P [Helicobacter pylori--2002]. 2002 Praxis (Bern 1994) pmid:12071078
Steurer J [Months of antibiotic therapy in persistent symptoms of Lyme disease without effect]. 2016 Praxis (Bern 1994) pmid:27269781
Dobrick N et al. [Legionnaires disease (legionella pneumonia)]. 2012 Praxis (Bern 1994) pmid:23147600
Schuster M [Helicobacter pylori: reasons for eradication]. 2004 Praxis (Bern 1994) pmid:15672764
Schuster MJ [Helicobacter pylori. Update 2002]. 2002 Praxis (Bern 1994) pmid:12508673
Landolt M and Heininger U [Prevalence of perianal streptococcal dermatitis in children and adolescents]. 2005 Praxis (Bern 1994) pmid:16209362
Coulston J and Balaratnam N Irreversible sensorineural hearing loss due to clarithromycin. 2005 Postgrad Med J pmid:15640431
Bateson MC Quadruple therapy for symptomatic spontaneous duodenal ulcer disease. 2001 Postgrad Med J pmid:11423595
Laird-Fick HS et al. Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. 2016 Postgrad Med J pmid:27222587
Laine L and Fendrick AM Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment. 1998 Postgrad Med pmid:9519040
Senatore FJ et al. Helicobacter pylori treatment: Still a work in progress. 2016 Postgrad Med pmid:26490697
Prescott LM Clarithromycin for MAC prevention offers additional benefits. 1996 May-Jun Posit Aware pmid:11363431
Remer M et al. [Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)]. 2005 Pol. Merkur. Lekarski pmid:16358864
Maciorkowska E et al. [Resistance to antibiotics used in Helicobacter pylori infection in children]. 2004 Pol. Merkur. Lekarski pmid:15510893
Andrzejewska E et al. Antimicrobial resistance of Helicobacter pylori clinical strains in the last 10 years. 2009 Pol. J. Microbiol. pmid:20380140
Namiot Z et al. [The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication]. 2000 Pol. Arch. Med. Wewn. pmid:11392163
Walicka M et al. Mycoplasma pneumoniae-induced pneumonia with Stevens-Johnson syndrome of acute atypical course. Pol. Arch. Med. Wewn. pmid:18714743
Bartnik W Clinical aspects of Helicobacter pylori infection. Pol. Arch. Med. Wewn. pmid:18714738
Bocheńska-Marciniak M et al. [Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections]. 1998 Pol. Arch. Med. Wewn. pmid:10335027
Aktan B et al. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. 2003 Nov-Dec Pol J Pharmacol pmid:14730107
Radzikowska E et al. [Organizing pneumonia--own experiences with clarithromycin treatment]. 2004 Pneumonol Alergol Pol pmid:16329349
Radzikowska E et al. [Organizing pneumonia--clarithromycin treatment]. 2008 Pneumonol Alergol Pol pmid:19003763
Michałowska-Mitczuk D [Patients with chronic sputum positive tuberculosis-a therapeutic problem]. 1995 Pneumonol Alergol Pol pmid:7633360
Buraczewska A et al. [Mycobacterial infection caused by Mycobacterium avium in allogenic bone marrow transplant recipient with concomittant bronchiolitis obliterans as a manifestation of graft versus host disease - case report and review of the literature]. 2008 Pneumonol Alergol Pol pmid:18464226
Radzikowska E et al. [Organizing pneumonia--analysis of 18 own cases]. 2004 Pneumonol Alergol Pol pmid:15757271
Schreiber J et al. [Non-tubercular mycobacterial infection of the lungs due to Mycobacterium smegmatis]. 2001 Pneumologie pmid:11449609
[Bronchial asthma--clarithromycin depresses neutrophil inflammation]. 2009 Pneumologie pmid:19165701
Handrick W et al. [Pulmonary infection due to Mycobacterium malmoense]. 2005 Pneumologie pmid:15944898
Marsollier L et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 2007 PLoS Pathog. pmid:17480118
Dorer MS et al. DNA damage triggers genetic exchange in Helicobacter pylori. 2010 PLoS Pathog. pmid:20686662
Namkoong H et al. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia. 2018 PLoS Pathog. pmid:29621339
Ankomah P and Levin BR Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. 2012 PLoS Pathog. pmid:22253599
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Cusini A et al. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. 2010 PLoS ONE pmid:21103362
Davies EC et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. 2009 PLoS ONE pmid:19209224
Lee SJ et al. Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice. 2015 PLoS ONE pmid:26114656
Eickel V et al. Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients. 2009 PLoS ONE pmid:19247473
Yonezawa H et al. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. 2013 PLoS ONE pmid:24039906
McNaghten AD et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. 2007 PLoS ONE pmid:17579722
Greenstein RJ et al. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. 2007 PLoS ONE pmid:17565369
Huh CW et al. Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. 2016 PLoS ONE pmid:27588679
Greenstein RJ et al. Vitamins A & D inhibit the growth of mycobacteria in radiometric culture. 2012 PLoS ONE pmid:22235314
Christianson S et al. Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. 2016 PLoS ONE pmid:27490181
Liou JM et al. The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study. 2015 PLoS ONE pmid:25942450
Greenstein RJ et al. On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. 2008 PLoS ONE pmid:18575598
Ren YR et al. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. 2008 PLoS ONE pmid:19104661
Ishiguro N et al. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. 2017 PLoS ONE pmid:28288170
Greenstein RJ et al. The thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in culture. 2010 PLoS ONE pmid:20559419
Hirasawa K et al. Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. 2016 PLoS ONE pmid:27977675
Shinahara W et al. Immunomodulator clarithromycin enhances mucosal and systemic immune responses and reduces re-infection rate in pediatric patients with influenza treated with antiviral neuraminidase inhibitors: a retrospective analysis. 2013 PLoS ONE pmid:23875018
Greenstein RJ et al. On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. 2007 PLoS ONE pmid:17252054
Peedikayil MC et al. Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials. 2014 PLoS ONE pmid:24465624
Jakobsson HE et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. 2010 PLoS ONE pmid:20352091
Chu HS et al. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. 2015 PLoS ONE pmid:25581038
Berende A et al. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease. 2018 PLoS ONE pmid:29608590
Dalkmann P et al. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. 2012 PLoS ONE pmid:23049795
Andersen JT et al. Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. 2013 PLoS ONE pmid:23301061
Juste RA et al. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. 2008 PLoS ONE pmid:18596984
Wu TS et al. Fish tank granuloma caused by Mycobacterium marinum. 2012 PLoS ONE pmid:22911774
Raymond J et al. Using macro-arrays to study routes of infection of Helicobacter pylori in three families. 2008 PLoS ONE pmid:18493595
Hashim H et al. Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. 2014 PLoS ONE pmid:25411976
Robertson HT and Allison DB Drugs associated with more suicidal ideations are also associated with more suicide attempts. 2009 PLoS ONE pmid:19798416
Ramírez-Lázaro MJ et al. Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding. 2011 PLoS ONE pmid:21625499
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Blumenthal A et al. M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. 2012 PLoS ONE pmid:22649518
Matsumoto Y et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. 2011 PLoS ONE pmid:21533264
Ripoll F et al. Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. 2009 PLoS ONE pmid:19543527
Boisson-Dupuis S et al. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. 2011 PLoS ONE pmid:21533230
van der Linden M et al. Molecular characterization of pneumococcal isolates from pets and laboratory animals. 2009 PLoS ONE pmid:20011527
Lu ZM et al. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. 2012 PLoS ONE pmid:22558275
Everett DB et al. Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. 2011 PLoS ONE pmid:21423577
Wu Y et al. Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection. 2013 PLoS ONE pmid:23573226
Desai S et al. The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013. 2015 PLoS ONE pmid:26569613
Hardy RD et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. 2009 PLoS ONE pmid:19859545
Ribeiro CM et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. 2009 PLoS ONE pmid:19503797
Teh X et al. Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur. 2014 PLoS ONE pmid:25003707
Radzikowska E et al. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study. 2017 PLoS ONE pmid:28945804
Vadwai V et al. Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities. 2011 PLoS ONE pmid:21935462
Hahn DL et al. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. 2012 PLoS ONE pmid:22545149
Tan B et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. 2017 PLoS ONE pmid:28407007
Rubio M et al. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. 2015 PLoS ONE pmid:26448181
Shea BJ et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). 2007 PLoS ONE pmid:18159233
Martins TG et al. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. 2012 PLoS ONE pmid:22393444
Li Y et al. A data-driven predictive approach for drug delivery using machine learning techniques. 2012 PLoS ONE pmid:22384063
Lai JF et al. Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae. 2010 PLoS ONE pmid:21203444